Junqi He

4.1k total citations · 1 hit paper
87 papers, 3.4k citations indexed

About

Junqi He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junqi He has authored 87 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 16 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Junqi He's work include Receptor Mechanisms and Signaling (12 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Junqi He is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (6 papers). Junqi He collaborates with scholars based in China, United States and United Kingdom. Junqi He's co-authors include Xu Teng, Fangqiong Tang, Dong Chen, Xinglu Huang, Randy A. Hall, Huiyu Liu, Linlin Li, Jianguo Xu, Amanda M. Castleberry and Junfang Zheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and ACS Nano.

In The Last Decade

Junqi He

82 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function

2009 825 citations Xinglu Huang, Xu Teng et al. Biomaterials profile →

Peers

Countries citing papers authored by Junqi He

Since Specialization

Citations

This map shows the geographic impact of Junqi He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqi He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqi He more than expected).

Fields of papers citing papers by Junqi He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqi He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqi He. The network helps show where Junqi He may publish in the future.

Co-authorship network of co-authors of Junqi He

This figure shows the co-authorship network connecting the top 25 collaborators of Junqi He. A scholar is included among the top collaborators of Junqi He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqi He. Junqi He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative analysis of AI models in disseminating genetic counseling knowledge for gynecologic cancers 2025 ·International Journal of Gynecology & Obstetrics ·(unknown), Junqi He, (unknown)	0
2	Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies 2025 ·Frontiers in Pharmacology ·(unknown), (unknown), Junqi He, Lei Su, (unknown), (unknown), Qin Yao	1
3	A targetable OSGIN1 − AMPK − SLC2A3 axis controls the vulnerability of ovarian cancer to ferroptosis 2025 ·npj Precision Oncology ·(unknown), Fan Tang, (unknown), Yanqin Zhang, (unknown), (unknown), Yubo Zhang, (unknown), (unknown), Junqi He, (unknown)	5
4	B7-H3-mediated reversal of CAR-T cell exhaustion induces a notable antitumour response in ovarian cancer models 2025 ·EBioMedicine ·Qun Liu, (unknown), (unknown), Fan Tang, (unknown), (unknown), (unknown), (unknown), Di Wu, (unknown), (unknown), Junqi He, (unknown)	0
5	PDZK1 confers sensitivity to sunitinib in clear cell renal cell carcinoma by suppressing the PDGFR-β pathway 2024 ·British Journal of Cancer ·(unknown), Lijie Zhang, (unknown), Yumeng Yang, (unknown), (unknown), Xiaomei Yang, (unknown), (unknown), Duiping Feng, (unknown), (unknown), Junqi He	6
6	NHERF4 hijacks Mas-mediated PLC/AKT signaling to suppress the invasive potential of clear cell renal cell carcinoma cells 2021 ·Cancer Letters ·Ying Yang, (unknown), Chunjuan Zhao, Yibin Chen, Siyu Gu, Xiaomei Yang, Hua Liu, Qiong Qin, Haibo Wang, (unknown), (unknown), Duiping Feng, Junqi He	3
7	Whole-Tooth Regeneration by Allogeneic Cell Reassociation in Pig Jawbone 2019 ·Tissue Engineering Part A ·Zhifang Wu, Fu Wang, Zhipeng Fan, Tingting Wu, Junqi He, Jinsong Wang, Chunmei Zhang, (unknown)	17
8	NHERF1 inhibits beta-catenin-mediated proliferation of cervical cancer cells through suppression of alpha-actinin-4 expression 2018 ·Cell Death and Disease ·Qiqi Wang, Qiong Qin, Ran Song, Chunjuan Zhao, Hua Liu, Ying Yang, Siyu Gu, Deshan Zhou, Junqi He	24
9	A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression 2017 ·Anticancer Research ·Xiaomei Yang, Guifang Du, (unknown), Si Yang, Tracey A. Martin, Junqi He, Shan Cheng, Wen G. Jiang	11
10	Global Analysis of miRNA–mRNA Interaction Network in Breast Cancer with Brain Metastasis 2017 ·Anticancer Research ·Zhixin Li, Zhiqiang Peng, Siyu Gu, Junfang Zheng, Duiping Feng, Qiong Qin, Junqi He	25
11	EBP50 Phosphorylation by Cdc2/Cyclin B Kinase Affects Actin Cytoskeleton Reorganization and Regulates Functions of Human Breast Cancer Cell Line MDA-MB-231 2013 ·Molecules and Cells ·(unknown), Junfang Zheng, Shan Cheng, Duiping Feng, Junqi He	20
12	Breast cancer‐derived K172N, D301V mutations abolish Na⁺/H⁺ exchanger regulatory factor 1 inhibition of platelet‐derived growth factor receptor signaling 2013 ·FEBS Letters ·Shan Cheng, Yang Li, Ying Yang, Duiping Feng, Longyan Yang, Qian Ma, Shuai Zheng, Ran Meng, Shuhui Wang, Songlin Wang, Wen G. Jiang, Junqi He	17
13	MicroRNAome and Expression Profile of Developing Tooth Germ in Miniature Pigs 2012 ·PLoS ONE ·Ang Li, Tieli Song, Fu Wang, Dayong Liu, Zhipeng Fan, Chunmei Zhang, Junqi He, Songlin Wang	23
14	Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice 2010 ·Biomaterials ·Tianlong Liu, Linlin Li, Xu Teng, Xinglu Huang, Huiyu Liu, Dong Chen, Jun Ren, Junqi He, Fangqiong Tang	297
15	Beta‐2 adrenergic receptor mediated ERK activation is regulated by interaction with MAGI‐3 2010 ·FEBS Letters ·Xiaomei Yang, Junfang Zheng, Ying Xiong, Hui Shen, (unknown), Yan Huang, (unknown), Yang Li, Junqi He	25
16	EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity 2009 ·Amino Acids ·Junfang Zheng, (unknown), Hua Liu, Yan Huang, Li Yang, Junqi He	27
17	The PDZ domain protein CAL interacts with mGluR5a and modulates receptor expression 2009 ·Journal of Neurochemistry ·Shan Cheng, (unknown), Ping Zhu, Yanmei Ma, Ying Xiong, (unknown), Jianguo Xu, Hong Zhang, Junqi He	26
18	Disabled-2 Is Essential for Endodermal Cell Positioning and Structure Formation during Mouse Embryogenesis 2002 ·Developmental Biology ·Dong‐Hua Yang, Elizabeth R. Smith, Isabelle Roland, Zejuan Sheng, Junqi He, William Martin, Thomas C. Hamilton, J. David Lambeth, Xiang‐Xi Xu	140
19	Disabled-2 Exerts Its Tumor Suppressor Activity by Uncoupling c-Fos Expression and MAP Kinase Activation 2001 ·Journal of Biological Chemistry ·Junqi He, Elizabeth R. Smith, (unknown)	37
20	Structure, Sequence, and Promoter Analysis of Human Disabled-2 Gene (DAB2) 2000 ·Genomics ·Zejuan Sheng, Junqi He, (unknown), Wenping Sun, Zia Fazili, Elizabeth Smith, Dong Feng, Xiang‐Xi Xu	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact